Dr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (NPC), a rare head and neck cancer. This marks India as the ...

Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal ...

Dr Reddy's Laboratories has launched Toripalimab, a groundbreaking drug for treating recurrent or metastatic nasopharyngeal carcinoma (NPC) in India. The drug, marketed as Zytorvi, addresses an unmet ...

The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

Dr Reddy’s had obtained exclusive rights to develop and commercialise Toripalimab in 21 countries including India, South ...

“The launch of Toripalimab is a significant milestone for patients diagnosed with nasopharyngeal carcinoma (NPC) in India.

Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...

Lead researcher Jin Hokyung said, "Our study identified the nasopharyngeal lymphatic plexus as a hub for CSF outflow. CSF ...

Researchers are continuing to study nasopharyngeal carcinoma (NPC) to understand how it develops and what it responds to. Their goal is to provide better outcomes and possible prevention.

Surgery is not a common treatment for nasopharyngeal cancer. This is because the area is difficult to reach and surrounded by important nerves and blood vessels. You are most likely to have surgery to ...

Considering taking supplements to treat nasopharyngeal cancer? Below is a list of common natural remedies used to treat or reduce the symptoms of nasopharyngeal cancer. Follow the links to read ...